Abstract
Substance abuse refers to the maladaptive use of any chemical, legal or illicit, to produce alterations in brain functioning, mood, behavior, and/or level of perception. There are at least three different ways in which substance abuse may result in substantial child and adolescent psychiatric morbidity: (1) exposure during gestation to substances with known behavioral teratogenicity; (2) psychosocial deprivation and/or physical harm as a result of caretakers’ substance abuse disorders; and (3) substance abuse disorders and their consequences in children and adolescents themselves. This chapter will focus specifically on the child and adolescent psychopathology associated with substance abuse as well as the psychopharmacology of the substances involved.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schuckit MA: Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment, ed 3. New York, Plenum Press, 1989.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, DC, American Psychiatric Association Press, 1994.
Hindmarsh KW, Opheim EE: Drug abuse prevalence in Western Canada and the Northwest Territories: A survey of students in grades 6–12. Int J Addict 25:310–315, 1990.
Hartnoll R, Avico U, Ingold FR, et al: A multicity study of drug use in Europe. Bull Narcotics 41:3–27, 1989.
Johnston LD, Bachman J, O’Malley P: Press release from the “Monitoring the Future: A Continuing Study of the Lifestyles and Values of Youth” study. Ann Arbor, University of Michigan Institute for Social Research, December 11, 1995.
Oetting ER, Beauvais F: Adolescent drug use: Findings of national and local surveys. J Consult Clin Psychol 58:385–394, 1990.
Bailey GW: Current perspectives on substance abuse in youth. J Am Acad Child Adolesc Psychiatry 28:151–162, 1989.
Kumpfer KL: Prevention of alcohol and drug abuse: A critical review of risk factors and prevention strategies, in Shaffer D, Philips I, Enzer NB (eds): Prevention of Mental Disorders, Alcohol and Other Drug Use in Children and Adolescents. Rockville, Md, US Department of Health and Human Services, 1989.
Johnston LD, O’Malley PM, Bachman JG: National Survey Results on Drug Use from The Monitoring the Future Study, 1975–1994, Volume 1. The University of Michigan Institute for Social Research. Rockville, Md, US Department of Health and Human Services, 1995.
Bachman JG, Wallace JM Jr, O’Malley PM, et al: Press release from the “Monitoring the Future: A Continuing Study of the Lifestyles and Values of Youth” study. Ann Arbor, University of Michigan Institute for Social Research, February 25, 1991.
Cloninger CR, Sigvardsson S, Bohman M: Childhood personality predicts alcohol abuse in young adults. Alcoholism Clin Exp Res 12:494–505, 1988.
Halikas J: Substance abuse in children and adolescents, in Garfinkel BD, Carlson GA, Weller EB (eds): Psychiatric Disorders in Children and Adolescents. Philadelphia, WB Saunders Co, 1990.
Weiss G, Hechtman L, Perlman T, et al: Hyperactives as young adults: A controlled prospective ten-year follow-up of 75 children. Arch Gen Psychiatry 36:675–681, 1983.
Dinwiddle SH, Cloninger CR: Family and adoption studies in alcoholism and drug addiction. Psychiatr Ann 21:206–214, 1991.
Schuckit MA, Gold EO: A simultaneous evaluation of multiple markers of ethanol and placebo challenges in sons of alcoholics and controls. Arch Gen Psychiatry 45:211–216, 1988.
Cloninger CR: Neurogenetic adaptive mechanisms in alcoholism. Science 236:410–416, 1987.
Shaffer D, Garland A, Gould M, et al: Preventing teenage suicide: A critical review. J Am Acad Child Adolesc Psychiatry 26:675–687, 1988.
Macdonald DI: Patterns of alcohol and drug use among adolescents. Pediatr Clin North Am 34:275–288, 1987.
Kandel DB: Stages in adolescent involvement in drug use. Science 190:912–914, 1975.
Bukstein O: Practice parameters for child and adolescent substance abuse. J Am Acad Child Adolesc Psychiatry, in press.
Woolf AD, Shanon MW: Clinical toxicology for the pediatrician. Pediatr Clin North Am 42:317–333, 1995.
Myers WC, Donahue JE, Goldstein MR: Disulfiram for alcohol use disorders in adolescents. J Am Acad Child Adolesc Psychiatry 33:484–489, 1994.
Kaminer Y: Pharmacotherapy for adolescents with psychoactive substance use disorders. NIDA Research Monograph 156:291–324, 1995.
Meadows R, Verghese A: Medical complications of glue sniffing. S Med J 89(5):455–462, 1996.
Hansen WB, Rose LA: Recreational use of inhalant drugs by adolescents: A challenge for family physicians. Fam Med 27(6):383–387, 1995.
American Psychiatric Association: Practice guideline for the treatment of patients with nicotine dependence. Am J Psychiatry (suppl) 153(10):1–31, (1996).
Montgomery PT, Mueller ME: Treatment of PCP intoxication with verapamil. Am J Psychiatry 142:882, 1985.
Silverman PB: Direct dopamine agonist-like activity conditioned to cocaine. Pharmacol Biochem Behav 37:231–234, 1990.
Bukstein O: Treatment of adolescent alcohol abuse and dependence. Alcohol Health Res World. 18(4):296–301, 1994.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Eisner, A., McClellan, J. (1999). Drugs of Abuse. In: Werry, J.S., Aman, M.G. (eds) Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0086-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0086-9_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45885-9
Online ISBN: 978-1-4899-0086-9
eBook Packages: Springer Book Archive